News & positions

NEWS UPDATES 30 March 2020

Johnson & Johnson – Together against COVID-19!


Johnson & Johnson and BARDA together commit more than $1 billion to novel Coronavirus vaccine research and development; company expects to initiate phase 1 human clinical studies of vaccine candidate at latest by September 2020.

LINK

(Source: Johnson & Johnson)